Literature DB >> 18923022

Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

Koen Poesen1, Diether Lambrechts, Philip Van Damme, Joke Dhondt, Florian Bender, Nicolas Frank, Elke Bogaert, Bart Claes, Line Heylen, An Verheyen, Katrien Raes, Marc Tjwa, Ulf Eriksson, Masabumi Shibuya, Rony Nuydens, Ludo Van Den Bosch, Theo Meert, Rudi D'Hooge, Michael Sendtner, Wim Robberecht, Peter Carmeliet.   

Abstract

Although vascular endothelial growth factor-B (VEGF-B) is a homolog of the angiogenic factor VEGF, it has only minimal angiogenic activity, raising the question of whether this factor has other (more relevant) biological properties. Intrigued by the possibility that VEGF family members affect neuronal cells, we explored whether VEGF-B might have a role in the nervous system. Here, we document that the 60 kDa VEGF-B isoform, VEGF-B(186), is a neuroprotective factor. VEGF-B(186) protected cultured primary motor neurons against degeneration. Mice lacking VEGF-B also developed a more severe form of motor neuron degeneration when intercrossed with mutant SOD1 mice. The in vitro and in vivo effects of VEGF-B(186) were dependent on the tyrosine kinase activities of its receptor, Flt1, in motor neurons. When delivered intracerebroventricularly, VEGF-B(186) prolonged the survival of mutant SOD1 rats. Compared with a similar dose of VEGF, VEGF-B(186) was safer and did not cause vessel growth or blood-brain barrier leakiness. The neuroprotective activity of VEGF-B, in combination with its negligible angiogenic/permeability activity, offers attractive opportunities for the treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18923022      PMCID: PMC6671326          DOI: 10.1523/JNEUROSCI.1092-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

1.  Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptors are expressed in neural cells.

Authors:  Cornel Popovici; Daniel Isnardon; Daniel Birnbaum; Régine Roubin
Journal:  Neurosci Lett       Date:  2002-08-23       Impact factor: 3.046

2.  Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells.

Authors:  Frauke Forstreuter; Ralph Lucius; Rolf Mentlein
Journal:  J Neuroimmunol       Date:  2002-11       Impact factor: 3.478

3.  Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.

Authors:  S P Gunningham; M J Currie; C Han; K Turner; P A Scott; B A Robinson; A L Harris; S B Fox
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  The role of p75NTR in modulating neurotrophin survival effects in developing motoneurons.

Authors:  S Wiese; F Metzger; B Holtmann; M Sendtner
Journal:  Eur J Neurosci       Date:  1999-05       Impact factor: 3.386

5.  Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect.

Authors:  K Aase; G von Euler; X Li; A Pontén; P Thorén; R Cao; Y Cao; B Olofsson; S Gebre-Medhin; M Pekny; K Alitalo; C Betsholtz; U Eriksson
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

6.  Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia.

Authors:  D Bellomo; J P Headrick; G U Silins; C A Paterson; P S Thomas; M Gartside; A Mould; M M Cahill; I D Tonks; S M Grimmond; S Townson; C Wells; M Little; M C Cummings; N K Hayward; G F Kay
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

7.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

Authors:  B Oosthuyse; L Moons; E Storkebaum; H Beck; D Nuyens; K Brusselmans; J Van Dorpe; P Hellings; M Gorselink; S Heymans; G Theilmeier; M Dewerchin; V Laudenbach; P Vermylen; H Raat; T Acker; V Vleminckx; L Van Den Bosch; N Cashman; H Fujisawa; M R Drost; R Sciot; F Bruyninckx; D J Hicklin; C Ince; P Gressens; F Lupu; K H Plate; W Robberecht; J M Herbert; D Collen; P Carmeliet
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

8.  Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor.

Authors:  M Sondell; F Sundler; M Kanje
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

Review 9.  Structure and function of VEGF/VEGF-receptor system involved in angiogenesis.

Authors:  M Shibuya
Journal:  Cell Struct Funct       Date:  2001-02       Impact factor: 2.212

10.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

View more
  52 in total

1.  VEGF-B: a thing of beauty.

Authors:  Xuri Li
Journal:  Cell Res       Date:  2010-06-08       Impact factor: 25.617

2.  Vascular endothelial growth factor protects post-ganglionic sympathetic neurones from the detrimental effects of hydrogen peroxide by increasing catalase.

Authors:  D H Damon
Journal:  Acta Physiol (Oxf)       Date:  2011-03-14       Impact factor: 6.311

Review 3.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

4.  VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions.

Authors:  Victor H Guaiquil; Zan Pan; Natalia Karagianni; Shima Fukuoka; Gemstonn Alegre; Mark I Rosenblatt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 5.  Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.

Authors:  Xinchun Pi; Liang Xie; Cam Patterson
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

6.  Isolation and enrichment of embryonic mouse motoneurons from the lumbar spinal cord of individual mouse embryos.

Authors:  Stefan Wiese; Thomas Herrmann; Carsten Drepper; Sibylle Jablonka; Natalia Funk; Alice Klausmeyer; Mary-Louise Rogers; Robert Rush; Michael Sendtner
Journal:  Nat Protoc       Date:  2009-12-17       Impact factor: 13.491

7.  Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis.

Authors:  Alice Brockington; Paul R Heath; Hazel Holden; Paul Kasher; Florian L P Bender; Filip Claes; Diether Lambrechts; Michael Sendtner; Peter Carmeliet; Pamela J Shaw
Journal:  BMC Genomics       Date:  2010-03-26       Impact factor: 3.969

Review 8.  The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

Authors:  Torsten Falk; Robert T Gonzalez; Scott J Sherman
Journal:  Int J Mol Sci       Date:  2010-08-05       Impact factor: 5.923

9.  Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.

Authors:  X Yue; D J Hariri; B Caballero; S Zhang; M J Bartlett; O Kaut; D W Mount; U Wüllner; S J Sherman; T Falk
Journal:  Neuroscience       Date:  2013-11-27       Impact factor: 3.590

10.  Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease.

Authors:  Torsten Falk; Shiling Zhang; Scott J Sherman
Journal:  Mol Neurodegener       Date:  2009-12-10       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.